Company Filing History:
1 out of 17 
1 out of 93 
1 out of 832,812 Years Active: 2011-2016
Title: Walter P Maksymowych: Innovator in Medical Treatments
Introduction
Walter P Maksymowych is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of medical treatments, particularly in the area of ankylosing spondylitis. With a total of 3 patents to his name, his work has the potential to impact many lives.
Latest Patents
Maksymowych's latest patents include innovative methods for the treatment of ankylosing spondylitis using TNF alpha antibodies. This invention provides methods, uses, and compositions for treating ankylosing spondylitis (AS). It describes how a TNFα inhibitor, such as a human TNFα antibody, can be used to reduce the signs and symptoms of AS in a subject. Additionally, he has developed methods for determining the efficacy of a TNFα inhibitor for treating ankylosing spondylitis. Another significant patent focuses on methods and compositions for diagnosing ankylosing spondylitis using biomarkers, which involves determining the efficacy of a TNFα inhibitor using collagen degradation and synovitis biomarkers.
Career Highlights
Throughout his career, Walter P Maksymowych has worked with prominent companies in the biotechnology sector, including Abbott Biotechnology Ltd. and AbbVie Biotechnology Ltd. His experience in these organizations has contributed to his expertise in developing innovative medical treatments.
Collaborations
Maksymowych has collaborated with notable professionals in his field, including Robert L Wong and Hartmut Kupper. These collaborations have likely enriched his research and development efforts.
Conclusion
Walter P Maksymowych stands out as an influential inventor in the medical field, particularly for his advancements in treating ankylosing spondylitis. His patents reflect a commitment to improving patient outcomes through innovative therapies.